Details of the Drug

General Information of Drug (ID: DMDYSMJ)

• Drug Name: MRX-8

Indication

Disease Entry	ICD 11	Status	REF
Gram-negative bacterial infection	1B74-1G40	Phase 1	[1]

• Cross-matching ID: TTD ID: D13VWF

References

• [1] ClinicalTrials.gov (NCT04649541) An Adaptive, Randomized, Double Blind, Placebo Controlled Three Part Study of the Safety, Tolerability, and Pharmacokinetics of MRX-8 Administered Intravenously to Healthy Volunteers in Single Ascending and Multiple Ascending Dose Cohorts. U.S.National Institutes of Health.